You are here

Home » CERID Bibliography

CERID Bibliography

Export 96 results:
[ Author(Asc)] Title Type Year
Filters: First Letter Of Last Name is G  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
G
Gulati RK, Kwan-Gett T, Hampson NB, Baer A, Shusterman D, Shandro JR, Duchin JS. Carbon monoxide epidemic among immigrant populations: King County, Washington, 2006. Am J Public Health. 2009 ;99(9):1687-92.
Gujjar R, Marwaha A, El Mazouni F, White J, White KL, Creason S, Shackleford DM, Baldwin J, Charman WN, Buckner FS, et al. Identification of a metabolically stable triazolopyrimidine-based dihydroorotate dehydrogenase inhibitor with antimalarial activity in mice. J Med Chem. 2009 ;52(7):1864-72.
Gujjar R, El Mazouni F, White KL, White J, Creason S, Shackleford DM, Deng X, Charman WN, Bathurst I, Burrows J, et al. Lead optimization of aryl and aralkyl amine-based triazolopyrimidine inhibitors of Plasmodium falciparum dihydroorotate dehydrogenase with antimalarial activity in mice. J Med Chem. 2011 ;54(11):3935-49.
Guiney DG, Libby S, Fang FC, Krause M, Fierer J. Growth-phase regulation of plasmid virulence genes in Salmonella. Trends Microbiol. 1995 ;3(7):275-9.
Guiney DG, Fang FC, Krause M, Libby S, Buchmeier NA, Fierer J. Biology and clinical significance of virulence plasmids in Salmonella serovars. Clin Infect Dis. 1995 ;21 Suppl 2:S146-51.
Guiney DG, Fang FC, Krause M, Libby S. Plasmid-mediated virulence genes in non-typhoid Salmonella serovars. FEMS Microbiol Lett. 1994 ;124(1):1-9.
Guiguemde AW, Shelat AA, Bouck D, Duffy S, Crowther GJ, Davis PH, Smithson DC, Connelly M, Clark J, Zhu F, et al. Chemical genetics of Plasmodium falciparum. Nature. 2010 ;465(7296):311-5.
Grimes M, Sahi SK, B Godornes C, Tantalo LC, Roberts N, Bostick D, Marra CM, Lukehart SA. Two mutations associated with macrolide resistance in Treponema pallidum: increasing prevalence and correlation with molecular strain type in Seattle, Washington. Sex Transm Dis. 2012 ;39(12):954-8.
Greenblatt RM, Lukehart SA, Plummer FA, Quinn TC, Critchlow CW, Ashley RL, D'Costa LJ, Ndinya-Achola JO, Corey L, Ronald AR. Genital ulceration as a risk factor for human immunodeficiency virus infection. AIDS. 1988 ;2(1):47-50.
Greenblatt RM, Jacobson LP, Levine AM, Melnick S, Anastos K, Cohen M, DeHovitz J, Young MA, Burns D, Miotti P, et al. Human herpesvirus 8 infection and Kaposi's sarcoma among human immunodeficiency virus-infected and -uninfected women. J Infect Dis. 2001 ;183(7):1130-4.
Gray RR, Mulligan CJ, Molini BJ, Sun ES, Giacani L, Godornes C, Kitchen A, Lukehart SA, Centurion-Lara A. Molecular evolution of the tprC, D, I, K, G, and J genes in the pathogenic genus Treponema. Mol Biol Evol. 2006 ;23(11):2220-33.
Graham SM, Mwilu R, W Liles C. Clinical utility of biomarkers of endothelial activation and coagulation for prognosis in HIV infection: A systematic review. Virulence. 2013 ;4(6):564-71.
Graham SM, Rajwans N, Tapia KA, Jaoko W, Estambale BBa, R McClelland S, Overbaugh J, W Liles C. A prospective study of endothelial activation biomarkers, including plasma angiopoietin-1 and angiopoietin-2, in Kenyan women initiating antiretroviral therapy. BMC Infect Dis. 2013 ;13(1):263.
Graham SM, Rajwans N, Jaoko W, Estambale BBA, R McClelland S, Overbaugh J, W Liles C. Endothelial activation biomarkers increase after HIV-1 acquisition: plasma vascular cell adhesion molecule-1 predicts disease progression. AIDS. 2013 ;27(11):1803-13.
Gottlieb GS, Lesser CF, Holmes KK, Wald A. Disseminated sporotrichosis associated with treatment with immunosuppressants and tumor necrosis factor-alpha antagonists. Clin Infect Dis. 2003 ;37(6):838-40.
Gottlieb GS. Changing HIV epidemics: what HIV-2 can teach us about ending HIV-1. AIDS. 2013 ;27(1):135-7.
Gottlieb GS, Hawes SE, Nickle DC, Herbeck JT, Kiviat NB, Mullins JI, Sow PSalif. Presenting plasma HIV RNA level and rate of CD4 T-cell decline. JAMA. 2007 ;297(8):805; author reply 806-7.
Gottlieb GS, Eholié S-P, Nkengasong JN, Jallow S, Rowland-Jones S, Whittle HC, Sow PSalif. A call for randomized controlled trials of antiretroviral therapy for HIV-2 infection in West Africa. AIDS. 2008 ;22(16):2069-72; discussion 2073-4.
Gottlieb GS, Wald A, Agoff N. Unusual appendicitis. Clin Infect Dis. 2003 ;37(10):1334, 1378-9.
Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Kaslow RA, Shepherd JC, Margolick JB, Mullins JI. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report. Clin Infect Dis. 2007 ;45(4):501-9.
Gottlieb GS, Mullins JI. Re: Follow-up study of intrahost HIV type 2 variability reveals discontinuous evolution of C2V3 sequences. AIDS Res Hum Retroviruses. 2001 ;17(16):1563-5, 1567.
Gottlieb GS, Badiane NMery Dia, Hawes SE, Fortes L, Toure M, Ndour CT, Starling AK, Traore F, Sall F, Wong KG, et al. Emergence of multiclass drug-resistance in HIV-2 in antiretroviral-treated individuals in Senegal: implications for HIV-2 treatment in resouce-limited West Africa. Clin Infect Dis. 2009 ;48(4):476-83.
Gottlieb GS, Nickle DC, Jensen MA, Wong KG, Grobler J, Li F, Liu S-L, Rademeyer C, Learn GH, Karim SSAbdool, et al. Dual HIV-1 infection associated with rapid disease progression. Lancet. 2004 ;363(9409):619-22.
Gottlieb GS, Heath L, Nickle DC, Wong KG, Leach SE, Jacobs B, Gezahegne S, Wout AB van 't, Jacobson LP, Margolick JB, et al. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J Infect Dis. 2008 ;197(7):1011-5.
Gottlieb GS, Sow PSalif, Hawes SE, Ndoye I, Redman M, Coll-Seck AM, Faye-Niang MA, Diop A, Kuypers JM, Critchlow CW, et al. Equal plasma viral loads predict a similar rate of CD4+ T cell decline in human immunodeficiency virus (HIV) type 1- and HIV-2-infected individuals from Senegal, West Africa. J Infect Dis. 2002 ;185(7):905-14.

Pages